| Regimens Used in ATP Assay Randomized Trial | ||
| in Platinum-Resistant Ovarian Cancer | ||
| Drug/Combination | # of Times Selected by Assay | # of Times Selected by Clinician |
| Gemcitabine/Treosulfan | 31 | 18 |
| Taxol/Mitoxantrone | 23 | 13 |
| Gemcitabine/Platinum | 10 | 10 |
| Doxil (single) | 5 | 9 |
| Taxol/Epirubicin | 5 | 5 |
| Treosulfan/Epirubicin | 3 | 3 |
| Mitoxantrone (single) | 2 | 1 |
| Topotecan (single) | 1 | 9 |
| Treosulfan (single) | 1 | 1 |
| Cisplatin/Etoposide | 0 | 1 |
| Etoposide (single) | 0 | 3 |
| Taxol (single) | 0 | 5 |
| Total | 81 | 78 |